Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

S. Rosenberg, Eli; Dufort, Elizabeth; Udo, Tomoko; A. Wilberschied, Larissa; Kumar, Jessica; M. Tesoriero, James; Weinberg, Patti; Kirkwood, James; Muse, Alison; DeHovitz, Jack; Blog, Debra; Hutton, Brad; R. Holtgräve, David; A. Zucker, Howard

doi:10.1001/jama.2020.8630

Public

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Published in JAMA • May 12, 2020

Authors:

Eli S. Rosenberg

Elizabeth Dufort

Tomoko Udo

Abstract

Importance: Hydroxychloroquine, with or without azithromycin, has been considered as a possible therapeutic agent for patients with coronavirus disease 2019 (COVID-19). However, there are limited data on efficacy and associated adverse events. Objective: To describe the association between use of hy...

Subject

Hydroxychloroquine

Medicine

Azithromycin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!